Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Stockwatch: Specialty Pharma Falling

Executive Summary

If this downbeat first-quarter earnings season has claimed a scalp, it is the business model of specialty pharmaceutical companies. Last week the analysts from Jefferies described the specialty pharmaceutical sector as being in freefall.

Advertisement

Related Content

Papa's Exit Highlights Perrigo's Shortcomings
Teva to buy Allergan Generics; Mylan off the hook but Perrigo still wriggling

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register